App-Quantinova.ai

ANTEROLATERAL PAPILLARY MUSCLE RUPTURE DUE TO AN ISOLATED PAPILLARY MUSCLE INFARCT IN A PATIENT WITH NONISCHEMIC CARDIOMYOPATHY

Timothy D. McShurley - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Heart muscle disease

N/A

WHY DOES APICAL HYPERTROPHIC CARDIOMYOPATHY HAVE A FAVORABLE OUTCOME THAN NON-APICAL TYPES? CARDIAC MAGNETIC RESONANCE AND ECHOCARDIOGRAPHIC FINDINGS FROM 350 PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Eun Kyoung Kim - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

ASSOCIATION BETWEEN CONTRACTILE DYSFUNCTION OF THE SARCOMERE AND IMPAIRED REGIONAL SYSTOLIC STRAIN IN HYPERTROPHIC CARDIOMYOPATHY

Pieter A. Vriesendorp - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

ISCHEMIC CARDIOMYOPATHY IS ASSOCIATED WITH PLAQUE PROGRESSION AND HIGHER EVENT RATE IN PATIENTS POST-CARDIAC TRANSPLANTATION

Raviteja Reddy Guddeti - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

LONG-TERM OUTCOME AFTER MEDICAL AND INVASIVE TREATMENT IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Pieter A. Vriesendorp - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

EFFECT OF ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND RECEPTOR BLOCKERS ON APPROPRIATE IMPLANTABLE CARDIAC DEFIBRILLATOR SHOCK: INSIGHTS FROM THE GRADE MULTICENTER STUDY

Wael AlJaroudi - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Angiotensin II

LONG-TERM BENEFIT OF MYECTOMY AND ANTERIOR MITRAL LEAFLET EXTENSION IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY

Pieter A. Vriesendorp - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PARATHORMONE LEVELS ARE INDEPENDENTLY ASSOCIATED WITH THE PRESENCE OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH CORONARY ARTERY DISEASE

Alvaro Acena - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Parathyroid hormone

GALECTIN-3 AND MYOCARDIAL FIBROSIS AT CARDIAC MAGNETIC RESONANCE IN NONISCHEMIC DILATED CARDIOMYOPATHY

Giuseppe Vergaro - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

DOSE-DEPENDENCY AND EFFECTIVENESS OF CARDIAC GENE THERAPY WITH VEGF-B IN A PRE-CLINICAL MODEL OF DILATED CARDIOMYOPATHY

Felix J. Woitek - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

LONG-TERM OUTCOMES IN PATIENTS WITH LEFT VENTRICULAR NONCOMPACTION AND IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS

Tanya Shah - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

RENAL DENERVATION IN PATIENTS WITH NON ISCHEMIC CARDIOMYOPATHY AND CHRONIC HEART FAILURE

Nusen Beer - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

ANTIARRHYTHMIC EFFECT OF INVASIVE TREATMENT IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY: SIGNIFICANCE OF SUBSTRATE MODIFICATION DETECTED BY CARDIAC MRI

Tomohisa Nakamura - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

PERIPHERAL MICROVASCULAR FUNCTION IS ALTERED IN YOUNG INDIVIDUALS AT RISK FOR HYPERTROPHIC CARDIOMYOPATHY AND CORRELATES WITH DIASTOLIC MYOCARDIAL FUNCTION

Eva Fernlund - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Nitroprusside sodium

UNEXPECTED IDENTIFICATION OF FABRY DISEASE AMONG PATIENTS WITH THE CLINICAL DIAGNOSIS OF HYPERTROPHIC CARDIOMYOPATHY IN ICELAND

Berglind Adalsteinsdottir - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

alpha-galactosidase A

IMPACT OF SCN10A GENE POLYMORPHISM FOR CARDIAC CONDUCTION ABNORMALITY IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Akiyoshi Ogimoto - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

ALCOHOL SEPTAL ABLATION FOR HYPERTROPHIC CARDIOMYOPATHY DOES NOT MODIFY THE INCIDENCE OF ATRIAL FIBRILLATION

Travis J. Moss - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

FIRST RESULTS OF MICROSPHERE EMBOLIZATION AS AN ALTERNATIVE FOR ALCOHOL IN PERCUTANEOUS TRANSLUMINAL SEPTAL MYOCARDIAL ABLATION

Pieter A. Vriesendorp - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

HYPERTROPHIC CARDIOMYOPATHY WITH AORTOPATHY: A NOVEL ASSOCIATION

Rayan Yousefzai - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

N/A

AN ANALYSIS OF CARDIOGENIC SHOCK & CARDIAC ARREST IN APICAL BALLOONING SYNDROME (TAKOTSUBO/ STRESS CARDIOMYOPATHY): EVALUATING CLINICAL CHARACTERISTICS AND OUTCOMES

Sandeep M. Patel - American College of Cardiology (ACC) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

Filters

3340 Abstracts